In TP53WT ALL cell lines, Nalm-6 and RS4;11, as well as in the TP53MUT but functional REH cells, RG7388-mediated MDM2 inhibition resulted in an upregulation of p53 target genes (Figure 4A–C). This evidence concerns the gene MDM2 and acute lymphoblastic leukemia.